{"status":"OK","data":{"id":500695,"identifier":"MIISQV","persistentUrl":"https://doi.org/10.34894/MIISQV","protocol":"doi","authority":"10.34894","separator":"/","publisher":"DataverseNL","publicationDate":"2025-08-16","storageIdentifier":"surf://10.34894/MIISQV","effectiveDatasetFileCountLimit":10000,"datasetFileUploadsAvailable":9999,"datasetType":"dataset","locks":[],"latestVersion":{"id":31209,"datasetId":500695,"datasetPersistentId":"doi:10.34894/MIISQV","datasetType":"dataset","storageIdentifier":"surf://10.34894/MIISQV","versionNumber":1,"internalVersionNumber":7,"versionMinorNumber":0,"versionState":"RELEASED","latestVersionPublishingState":"RELEASED","deaccessionLink":"","distributionDate":"2023-09-28","lastUpdateTime":"2025-08-16T15:32:28Z","releaseTime":"2025-08-16T15:32:28Z","createTime":"2025-08-16T15:27:46Z","publicationDate":"2025-08-16","citationDate":"2025-08-16","effectiveDatasetFileCountLimit":10000,"datasetFileUploadsAvailable":9999,"license":{"name":"CC-BY-4.0","uri":"http://creativecommons.org/licenses/by/4.0","iconUri":"https://i.creativecommons.org/l/by/4.0/88x31.png"},"fileAccessRequest":true,"metadataBlocks":{"citation":{"displayName":"Citation Metadata","name":"citation","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"Pembrolizumab and Daratumumab indication broadening dates and dosages"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Heine, Renaud"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"https://ror.org/057w15z03","expandedvalue":{"scheme":"http://www.grid.ac/ontology/","termName":"Erasmus University Rotterdam","@type":"https://schema.org/Organization"}}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Heine, Renaud"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"https://ror.org/057w15z03"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"<p>This data set contains data on indication broadening dates and dosages for pembrolizumab and daratumumab.</p>"}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Other"]},{"typeName":"keyword","multiple":true,"typeClass":"compound","value":[{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Cbp Model"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Pembrolizumab"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Daratumumab"}}]},{"typeName":"topicClassification","multiple":true,"typeClass":"compound","value":[{"topicClassValue":{"typeName":"topicClassValue","multiple":false,"typeClass":"primitive","value":"Health Economics"}}]},{"typeName":"notesText","multiple":false,"typeClass":"primitive","value":"<p>This entry is a one-file data package totaling 42.8 KB, containing a file in .xlsx format.<p><p>If you use this dataset, please cite: Heine, Renaud (2023). Pembrolizumab and Daratumumab indication broadening dates and dosages. Erasmus University Rotterdam (EUR). Dataset. <a href=\"https://doi.org/10.25397/eur.24057333\" target=\"_blank\">https://doi.org/10.25397/eur.24057333</a><p>"},{"typeName":"distributionDate","multiple":false,"typeClass":"primitive","value":"2023-09-28"},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"Heine, Renaud"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2023-08-30"}]},"dansDataVaultMetadata":{"displayName":"Data Vault Metadata","name":"dansDataVaultMetadata","fields":[{"typeName":"dansDataversePid","multiple":false,"typeClass":"primitive","value":"doi:10.34894/MIISQV"},{"typeName":"dansDataversePidVersion","multiple":false,"typeClass":"primitive","value":"1.0"},{"typeName":"dansBagId","multiple":false,"typeClass":"primitive","value":"urn:uuid:09e1ee6c-8da1-434d-9d23-1fe7e5d221f3"},{"typeName":"dansNbn","multiple":false,"typeClass":"primitive","value":"urn:nbn:nl:ui:13-5d067b08-c880-4476-a3bf-f9c9083bbba6"}]}},"files":[{"description":"","label":"Data_CBP_pemrbolizumab_daratumumab.xlsx","restricted":false,"directoryLabel":"10.25397_eur.24057333","version":1,"datasetVersionId":31209,"categories":["Data"],"dataFile":{"id":500696,"persistentId":"","filename":"Data_CBP_pemrbolizumab_daratumumab.xlsx","contentType":"application/vnd.openxmlformats-officedocument.spreadsheetml.sheet","friendlyType":"MS Excel Spreadsheet","filesize":39689,"description":"","categories":["Data"],"storageIdentifier":"surf://store:198b37e7846-c82c6d4bc83b","rootDataFileId":-1,"checksum":{"type":"SHA-1","value":"0629f841605aa8e09274050782c6445b9b8f1fa4"},"tabularData":false,"creationDate":"2025-08-16","publicationDate":"2025-08-16","directoryLabel":"10.25397_eur.24057333","lastUpdateTime":"2025-08-16T15:32:28Z","fileAccessRequest":true}}]}}}